Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

University of Texas at Austin

Division of University of Texas
www.icmb.utexas.edu

Latest From University of Texas at Austin

Finance Watch: BIO Report Shows Record VC Funding Across Geographies

Private Company Edition: Venture capital for emerging therapeutics companies in the US and in ex-US regions reached all-time highs in 2018. Also, Alphamab raises $60m Series B, three new VC funds launch and FLX changes its name to RAPT.

Financing StartUps and SMEs

Venture Funding Deals: Vedanta Raises More Cash To Advance Microbiome Candidates

Cancer drug-developer Black Diamond emerges from stealth mode with Series A and closes Series B in the same month, while aging-focused Juvenescence closes its initial tranche and looks complete Series B by the end of the quarter. 

Deals Financing

Top 25 Start-Up VC Financings, H1 2015

Venture money has been flowing fast into biotech start-ups, shattering some fundraising records in the first half of this year. We present the top 25 VC deals of H1.

BioPharmaceutical Medical Device

Venture Funding Deals, November 2014

Derived from Strategic Transactions, a premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a  monthly review of emerging In Vitro  Diagnostic, Medical Device, and Pharmaceutical companies that have received venture funding. This month’s column covers deals announced September through October 2014.

BioPharmaceutical Medical Device
See All
Advertisement
Advertisement
UsernamePublicRestriction

Register